These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 17760809)

  • 1. Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence.
    van Hylckama Vlieg A; Christiansen SC; Luddington R; Cannegieter SC; Rosendaal FR; Baglin TP
    Br J Haematol; 2007 Sep; 138(6):769-74. PubMed ID: 17760809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombin generation in patients after acute deep-vein thrombosis.
    ten Cate-Hoek AJ; Dielis AW; Spronk HM; van Oerle R; Hamulyák K; Prins MH; ten Cate H
    Thromb Haemost; 2008 Aug; 100(2):240-5. PubMed ID: 18690343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endogenous thrombin potential and the risk of venous thromboembolism.
    Tripodi A; Martinelli I; Chantarangkul V; Battaglioli T; Clerici M; Mannucci PM
    Thromb Res; 2007; 121(3):353-9. PubMed ID: 17560633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin generation and activated protein C resistance in the absence of factor V Leiden correlates with the risk of recurrent venous thromboembolism in women aged 18-65 years.
    Sonnevi K; Tchaikovski SN; Holmström M; Rosing J; Bremme K; Lärfars G
    Thromb Haemost; 2011 Nov; 106(5):901-7. PubMed ID: 21947267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of coagulation factor XI as a risk factor for venous thrombosis.
    Meijers JC; Tekelenburg WL; Bouma BN; Bertina RM; Rosendaal FR
    N Engl J Med; 2000 Mar; 342(10):696-701. PubMed ID: 10706899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent thrombosis and survival after a first venous thrombosis of the upper extremity.
    Flinterman LE; van Hylckama Vlieg A; Rosendaal FR; Doggen CJ
    Circulation; 2008 Sep; 118(13):1366-72. PubMed ID: 18779446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombin generation as an intermediate phenotype for venous thrombosis.
    Segers O; van Oerle Rv; ten Cate Ht; Rosing J; Castoldi E
    Thromb Haemost; 2010 Jan; 103(1):114-22. PubMed ID: 20062924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous thrombin potential for predicting risk of venous thromboembolism in carriers of factor V Leiden.
    Lincz LF; Lonergan A; Scorgie FE; Rowlings P; Gibson R; Lawrie A; Seldon M
    Pathophysiol Haemost Thromb; 2006; 35(6):435-9. PubMed ID: 17565236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The routine determination of the endogenous thrombin potential, first results in different forms of hyper- and hypocoagulability.
    Wielders S; Mukherjee M; Michiels J; Rijkers DT; Cambus JP; Knebel RW; Kakkar V; Hemker HC; Béguin S
    Thromb Haemost; 1997 Apr; 77(4):629-36. PubMed ID: 9134633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
    De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
    Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oral contraceptives on thrombin generation measured via calibrated automated thrombography.
    Tchaikovski SN; van Vliet HA; Thomassen MC; Bertina RM; Rosendaal FR; Sandset PM; Helmerhorst FM; Tans G; Rosing J
    Thromb Haemost; 2007 Dec; 98(6):1350-6. PubMed ID: 18064335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overweight, obesity, and the risk of recurrent venous thromboembolism.
    Eichinger S; Hron G; Bialonczyk C; Hirschl M; Minar E; Wagner O; Heinze G; Kyrle PA
    Arch Intern Med; 2008 Aug; 168(15):1678-83. PubMed ID: 18695082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolism: risk factors for recurrence.
    Zhu T; Martinez I; Emmerich J
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating P-selectin and the risk of recurrent venous thromboembolism.
    Kyrle PA; Hron G; Eichinger S; Wagner O
    Thromb Haemost; 2007 Jun; 97(6):880-3. PubMed ID: 17549288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations.
    Pomp ER; le Cessie S; Rosendaal FR; Doggen CJ
    Br J Haematol; 2007 Oct; 139(2):289-96. PubMed ID: 17897305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged clot lysis time increases the risk of a first but not recurrent venous thrombosis.
    Karasu A; Baglin TP; Luddington R; Baglin CA; van Hylckama Vlieg A
    Br J Haematol; 2016 Mar; 172(6):947-53. PubMed ID: 26773756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low fasting methionine concentration as a novel risk factor for recurrent venous thrombosis.
    Keijzer MB; den Heijer M; Borm GF; Blom HJ; Vollset SE; Hermus AR; Ueland PM
    Thromb Haemost; 2006 Oct; 96(4):492-7. PubMed ID: 17003928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
    Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
    Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thrombosis of the upper extremity: effect of blood group and coagulation factor levels on risk.
    Flinterman LE; van Hylckama Vlieg A; Rosendaal FR; Doggen CJ
    Br J Haematol; 2010 Apr; 149(1):118-23. PubMed ID: 20096009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with deep venous thrombosis and thrombophilia risk factors have a specific prolongation of the lag time in a chromogenic thrombin generation assay.
    Haas FJ; Kluft C; Biesma DH; Schutgens RE
    Blood Coagul Fibrinolysis; 2011 Sep; 22(6):506-11. PubMed ID: 21537160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.